IRLA
Quince Therapeutics, Inc.
There isn't enough reported data to score IRLA yet.
IRLA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
IRLA's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
IRLA PE Valuation
IRLA has no meaningful PE right now: it lost money over the past year.
IRLA Forward outlook
There aren't enough analyst estimates for IRLA to show an outlook.
IRLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$154.71 | +$63.29 |
| Q1 2026 | -$210.40 | +$67.60 |
| Q4 2025 | -$336.00 | -$74.00 |
| Q3 2025 | -$242.00 | +$6.00 |
| Q2 2025 | -$218.00 | +$34.00 |
| Q1 2025 | -$278.00 | -$126.00 |
| Q4 2024 | -$262.00 | -$94.00 |
| Q3 2024 | -$248.00 | -$104.00 |
IRLA is still losing money, but far less than before: $154.71 per share over the past year, against $606.00 at its worst in late 2021.
IRLA Quarterly Revenue
IRLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$18.9M | -$7.3M |
| Q1 2026 | -$7.6M | +$2.1M |
| Q4 2025 | -$10.5M | -$2.8M |
| Q3 2025 | -$10M | -$2.7M |
| Q2 2025 | -$11.5M | -$2.8M |
| Q1 2025 | -$9.7M | -$1.4M |
| Q4 2024 | -$7.7M | -$1.6M |
| Q3 2024 | -$7.3M | -$2.5M |
IRLA has burned cash in almost every quarter: −$47M over the past year, against −$36M the year before.
IRLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1235% | +5.7M shares |
| 1 year | +2527% | +5.9M shares |
| 3 years | +3315% | +6M shares |
| 5 years | +4046% | +6M shares |
| Available history | +4470% | +6M shares |
IRLA has 6M diluted shares, up 2527% from a year ago.
IRLA Net Leverage
IRLA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IRLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 60.8 | Neutral |
IRLA's weekly RSI is 44 (neutral) and its Stochastic is 61 (neutral).
IRLA PE vs Healthcare Sector
IRLA has no meaningful PE right now: it lost money over the past year.
IRLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.6 | 22% above |
| 20 week MA | $28.9 | 38% above |
| 50 week MA | $132.9 | 70% below |
| 100 week MA | $223.2 | 82% below |
| 200 week MA | $226.9 | 82% below |
IRLA has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 82% below its 200-week average.
IRLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12,002.0 | $5,800.0 | -52% |
| 2021 | $5,800.0 | $2,656.0 | -54% |
| 2022 | $2,656.0 | $126.4 | -95% |
| 2023 | $126.4 | $210.0 | +66% |
| 2024 | $210.0 | $386.0 | +84% |
| 2025 | $386.0 | $712.0 | +84% |
| 2026 YTD | $712.0 | $39.8 | -94% |
IRLA has finished lower in three of the last six years. It's down 94% so far in 2026.